Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey


escrs app advert

Surgical treatment of neovascular glaucoma secondary to central retinal vien occlusion

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Glaucoma

Venue: Poster Village: Pod 2

First Author: : I.Pastukh UKRAINE

Co Author(s): :    T. Zimina   U. Diomin   N. Goncharova   U. Pastukh              

Abstract Details


To evaluate the efficacy of surgical treatment of neovascular glaucoma (NG) secondary to central retinal vien occlusion (CRVO).


Kharkiv Medical Academy of Postgraduate Education, Ophthalmology Department, Ukraine


Twelve adult patients (12 eyes) with NG after CRVO had intraocular pressure (IOP) 40-52 mm Hg and visual acute (VA) – hand movement. They received 1 intravitreal (IVT) injection of Aflibercept after paracentesis of anterior chamber (AC). One week after injection Trabeculectomy with iridocycloretraction was performed. IOP decreased. After 1-1,5 month phacoemulsification with intraocular lens (IOL) implantation was performed. After 3-4 weeks panretinal laser coagulation (PLC) performed for all eyes. Visometry, tonometry, biomicroscopy, the central retinal thickness (CRT) measured by optical coherence tomography, fundus photographs, and fluorescein angiography were evaluated.


One week after paracentesis of AC and IVT Aflibercept injection iris neovascularisation decreased and Trabeculectomy with iridocycloretraction was performed. Hyphema (1/3 – ¾ of AC) occurred in all cases. IOP become 12-15 mm Hg. After hyphema absorbtion Phacoemulsification with IOL implantation and PLC were performed. After 2 months of follow-up all patients gained VA on 10-20%. CRT showed a mean decrease of 55-65%. IOP had been normal. After 6 and 12 months of follow-up VA and IOP remained steady.


We used IVT Aflibercept injections to prepare patients with NG secondary to CRVO for surgical and laser treatment. Improvement of VA and IOP stabilization are very important for visually impaired patients of our group.

Financial Disclosure:


Back to previous